NDAQ Nasdaq Inc.

Delisting of Securities of Genesis Growth Tech Acquisition Corp.; Financial Strategies Acquisition Corp.; Kiromic BioPharma, Inc.; Infinity Pharmaceuticals, Inc.; Molekule Group, Inc.; EBET, Inc.; Shift Technologies, Inc.; Ontrak, Inc.; RVL Pharmaceutical

Delisting of Securities of Genesis Growth Tech Acquisition Corp.; Financial Strategies Acquisition Corp.; Kiromic BioPharma, Inc.; Infinity Pharmaceuticals, Inc.; Molekule Group, Inc.; EBET, Inc.; Shift Technologies, Inc.; Ontrak, Inc.; RVL Pharmaceuticals plc; Biocept, Inc.; Akumin Inc.; Appreciate Holdings, Inc.; Liberty TripAdvisor Holdings, Inc.; Tempo Automation Holdings, Inc.; Medicenna Therapeutics Corp.; RiceBran Technologies; and Acer Therapeutics Inc. from The Nasdaq Stock Market

NEW YORK, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the securities of Genesis Growth Tech Acquisition Corp. Genesis Growth Tech Acquisition Corp.’s securities were suspended on July 25, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Financial Strategies Acquisition Corp. Financial Strategies Acquisition Corp.’s securities were suspended on August 31, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Kiromic BioPharma, Inc. Kiromic BioPharma, Inc.’s securities were suspended on September 14, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc.’s securities were suspended on September 14, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Molekule Group, Inc. Molekule Group, Inc.’s securities were suspended on October 13, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of EBET, Inc. EBET, Inc.’s securities were suspended on October 13, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Shift Technologies, Inc. Shift Technologies, Inc.’s securities were suspended on October 19, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the preferred stock of Ontrak, Inc. Ontrak, Inc.’s securities were suspended on October 20, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of RVL Pharmaceuticals plc. RVL Pharmaceuticals plc’s securities were suspended on October 23, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Biocept, Inc. Biocept, Inc.’s securities were suspended on October 25, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Akumin Inc. Akumin Inc.’s securities were suspended on October 26, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Appreciate Holdings, Inc. Appreciate Holdings, Inc.’s securities were suspended on October 27, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Liberty TripAdvisor Holdings, Inc. Liberty TripAdvisor Holdings, Inc.’s securities were suspended on October 30, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Tempo Automation Holdings, Inc. Tempo Automation Holdings, Inc.’s securities were suspended on November 2, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Medicenna Therapeutics Corp. Medicenna Therapeutics Corp.’s securities were suspended on November 2, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of RiceBran Technologies. RiceBran Technologies’s securities were suspended on November 8, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Acer Therapeutics Inc. Acer Therapeutics Inc.’s securities were suspended on November 9, 2023, and have not traded on Nasdaq since that time.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at  Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: .



EN
17/11/2023

Underlying

NDAQNasdaq Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nasdaq Inc.

 PRESS RELEASE
Free
NDAQ NASDAQ INC.

Nasdaq Executives to Present at Upcoming Investor Conferences

Nasdaq Executives to Present at Upcoming Investor Conferences NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) will be presenting at the following conferences in March with webcasts available at Nasdaq’s Investor Relations website: . Who:Sarah Youngwood, Executive Vice President & Chief Financial Officer, NasdaqWhat:Morgan Stanley Technology, Media & Telecom ConferenceWhen:Monday, March 2nd, 11:30 AM ET  Who:Jeremy Skule, Executive Vice President, Chief Strategy Officer & Executive Chair, Financial Crime Management Technology, NasdaqWhat:Raymond James 47thAnnual Instituti...

February 26, 2026 1 EN
 PRESS RELEASE
Free
NDAQ NASDAQ INC.

Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Sto...

Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date February 13, 2026 NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- At the end of the settlement date of February 13, 2026, short interest in 3,595 Nasdaq Global MarketSM securities totaled 15,834,216,597 shares compared with 15,574,683,465 shares in 3,547 Global Market issues reported for the prior settlement date of January 30, 2026. The mid-January short interest represents 2.25 days compared with 2.58 days for the prior reporting period. Short interest in 1,654 securities on The Nasdaq Capital M...

February 25, 2026 1 EN
 PRESS RELEASE
Free
NDAQ NASDAQ INC.

Nasdaq Raises Medium‑Term Revenue Outlook and Outlines Strategy for It...

Nasdaq Raises Medium‑Term Revenue Outlook and Outlines Strategy for Its Next Phase of Scalable Growth at 2026 Investor Day Nasdaq raises medium-term Solutions revenue outlook to 9-12% growthMaintains medium-term outlook for expense growth of 5-8%Company reinforces its position as trusted transformation partner in the AI eraCommits to actioning AI productivity program with an expense efficiency target of $100 million by 2027 NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today will host its Investor Day at 8:00 a.m. ET, where Adena Friedman, Nasdaq Chair and CEO, Sarah ...

February 25, 2026 1 EN
NDAQ NASDAQ INC.

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Nasdaq, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 18 February 2026 in which we reassessed the appropriateness of the ratings in the context of t...

02/24/26 February 24, 2026 1 EN
 PRESS RELEASE
Free
NDAQ NASDAQ INC.

Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq ...

Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date January 30, 2026 NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- At the end of the settlement date of January 30, 2026, short interest in 3,547 Nasdaq Global MarketSM securities totaled 15,574,683,465 shares compared with 15,349,969,813 shares in 3,515 Global Market issues reported for the prior settlement date of January 15, 2026. The January short interest represents 2.58 days compared with 2.88 days for the prior reporting period. Short interest in 1,666 securities on The Nasdaq Capital Mark...

February 10, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch